Literature DB >> 26175949

FBXO31 promotes cell proliferation, metastasis and invasion in lung cancer.

Hai-Li Huang1, Yun Jiang2, Ya-Hong Wang1, Ting Chen1, Hui-Juan He1, Tie Liu3, Teng Yang1, La-Wei Yang1, Jie Chen4, Ze-Qing Song5, Weimin Yao5, Bin Wu5, Gang Liu2.   

Abstract

FBXO31 is a member of F-box family which is involved in diverse biological functions and development of disease. Recent reports in breast cancer, hepatocellular carcinoma and ovarian cancer demonstrated inhibitory effect of FBXO31 on proliferation and tumorigenesis. However, the function of FBXO31 is not analyzed in lung cancer so far. In this study, we reported that expression of FBXO31 was higher in lung cancer tissues compared with non-cancerous lung tissues, and that higher expression of FBXO31 was significantly associated with tumor size, tumor infiltration, clinical stages and lymph node metastasis. In addition, exogenous expression of FBXO31 promoted cell growth, metastasis and invasion in A549 cells. Conversely, silencing FBXO31 by specific siRNA caused inhibitory effect on cell growth, metastasis and invasion. Moreover, tumorigenicity assays in nude mice showed FBXO31 promoted tumor growth in vivo. In conclusion, our data suggest FBXO31 promotes cell proliferation, metastasis and invasion in lung cancer.

Entities:  

Keywords:  FBXO31; invasion; lung cancer; metastasis; tumor growth

Year:  2015        PMID: 26175949      PMCID: PMC4497447     

Source DB:  PubMed          Journal:  Am J Cancer Res        ISSN: 2156-6976            Impact factor:   6.166


  19 in total

1.  TSLC1 is a tumor-suppressor gene in human non-small-cell lung cancer.

Authors:  M Kuramochi; H Fukuhara; T Nobukuni; T Kanbe; T Maruyama; H P Ghosh; M Pletcher; M Isomura; M Onizuka; T Kitamura; T Sekiya; R H Reeves; Y Murakami
Journal:  Nat Genet       Date:  2001-04       Impact factor: 38.330

2.  A novel in vitro assay of tumor-initiating cells in xenograft prostate tumors.

Authors:  Christopher R Silvers; Karin Williams; Linda Salamone; Jiaoti Huang; Craig T Jordan; Haijun Zhou; Ganesh S Palapattu
Journal:  Prostate       Date:  2010-09-15       Impact factor: 4.104

3.  TAZ is a novel oncogene in non-small cell lung cancer.

Authors:  Z Zhou; Y Hao; N Liu; L Raptis; M-S Tsao; X Yang
Journal:  Oncogene       Date:  2011-01-24       Impact factor: 9.867

4.  FBXO31 determines poor prognosis in esophageal squamous cell carcinoma.

Authors:  Ryunosuke Kogo; Koshi Mimori; Fumiaki Tanaka; Shizuo Komune; Masaki Mori
Journal:  Int J Oncol       Date:  2011-04-28       Impact factor: 5.650

5.  FBXO31 is the chromosome 16q24.3 senescence gene, a candidate breast tumor suppressor, and a component of an SCF complex.

Authors:  Raman Kumar; Paul M Neilsen; Joanne Crawford; Ross McKirdy; Jaclyn Lee; Jason A Powell; Zarqa Saif; Julie M Martin; Marc Lombaerts; Cees J Cornelisse; Anne-Marie Cleton-Jansen; David F Callen
Journal:  Cancer Res       Date:  2005-12-15       Impact factor: 12.701

6.  The GATA2 transcriptional network is requisite for RAS oncogene-driven non-small cell lung cancer.

Authors:  Madhu S Kumar; David C Hancock; Miriam Molina-Arcas; Michael Steckel; Phillip East; Markus Diefenbacher; Elena Armenteros-Monterroso; François Lassailly; Nik Matthews; Emma Nye; Gordon Stamp; Axel Behrens; Julian Downward
Journal:  Cell       Date:  2012-04-27       Impact factor: 41.582

Review 7.  Tumor suppressor genes in human lung cancer.

Authors:  E Shimizu; S Sone
Journal:  J Med Invest       Date:  1997-08

8.  Amplification and expression of the c-myc oncogene in human lung cancer cell lines.

Authors:  C D Little; M M Nau; D N Carney; A F Gazdar; J D Minna
Journal:  Nature       Date:  1983 Nov 10-16       Impact factor: 49.962

9.  F-box proteins FBXO31 and FBX4 in regulation of cyclin D1 degradation upon DNA damage.

Authors:  Lijun Jia; Yi Sun
Journal:  Pigment Cell Melanoma Res       Date:  2009-07-23       Impact factor: 4.693

10.  The centrosomal E3 ubiquitin ligase FBXO31-SCF regulates neuronal morphogenesis and migration.

Authors:  Mayur Vadhvani; Nicola Schwedhelm-Domeyer; Chaitali Mukherjee; Judith Stegmüller
Journal:  PLoS One       Date:  2013-02-28       Impact factor: 3.240

View more
  13 in total

1.  FBXO25 promotes cell proliferation, invasion, and migration of NSCLC.

Authors:  Gui-Yang Jiang; Xiu-Peng Zhang; Liang Wang; Xu-Yong Lin; Juan-Han Yu; En-Hua Wang; Yong Zhang
Journal:  Tumour Biol       Date:  2016-09-05

Review 2.  Small molecule therapeutics targeting F-box proteins in cancer.

Authors:  Yuan Liu; Rama K Mallampalli
Journal:  Semin Cancer Biol       Date:  2015-09-30       Impact factor: 15.707

3.  Targeting NRASQ61K mutant delays tumor growth and angiogenesis in non-small cell lung cancer.

Authors:  Zhaowei Song; Fenghai Liu; Jie Zhang
Journal:  Am J Cancer Res       Date:  2017-04-01       Impact factor: 6.166

4.  Identification of HRAS as cancer-promoting gene in gastric carcinoma cell aggressiveness.

Authors:  Xiao Yu Wu; Wen Tao Liu; Zhen Feng Wu; Che Chen; Jia Yun Liu; Guan Nan Wu; Xue Quan Yao; Fu Kun Liu; Gang Li
Journal:  Am J Cancer Res       Date:  2016-09-01       Impact factor: 6.166

5.  Fms related tyrosine kinase 1 (Flt1) functions as an oncogene and regulates glioblastoma cell metastasis by regulating sonic hedgehog signaling.

Authors:  Kun Jiang; Yan-Ping Wang; Xiao-Dong Wang; Xiao-Bo Hui; Lian-Shu Ding; Ji Liu; Dai Liu
Journal:  Am J Cancer Res       Date:  2017-05-01       Impact factor: 6.166

6.  Celecoxib-erlotinib combination delays growth and inhibits angiogenesis in EGFR-mutated lung cancer.

Authors:  Yi Xiao Li; Jia Le Wang; Meng Gao; Hao Tang; Rong Gui; Yun Feng Fu
Journal:  Am J Cancer Res       Date:  2016-07-01       Impact factor: 6.166

7.  MiR-122 targets VEGFC in bladder cancer to inhibit tumor growth and angiogenesis.

Authors:  Yi Wang; Qing-Fei Xing; Xiao-Qiang Liu; Zhan-Jun Guo; Chang-Ying Li; Guang Sun
Journal:  Am J Transl Res       Date:  2016-07-15       Impact factor: 4.060

Review 8.  The role of F-box only protein 31 in cancer.

Authors:  Yuyong Tan; Deliang Liu; Jian Gong; Jia Liu; Jirong Huo
Journal:  Oncol Lett       Date:  2018-01-17       Impact factor: 2.967

9.  [Effect of Long Non-coding RNA SPRY4-IT1 on Invasion and Migration of A549 Cells].

Authors:  Song Chai; Wenting An; Lili Guo; Le Jiang; Zhisong Gao; Shujun Li
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2015-08

Review 10.  Prognostic values of F-box members in breast cancer: an online database analysis and literature review.

Authors:  Xiaochen Wang; Tao Zhang; Shizhen Zhang; Jinlan Shan
Journal:  Biosci Rep       Date:  2019-01-03       Impact factor: 3.840

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.